These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36898677)

  • 21. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing blood pressure control in dialysis patients: finally a step forward.
    Hopkins K; Bakris GL
    Hypertension; 2009 Mar; 53(3):448-9. PubMed ID: 19153262
    [No Abstract]   [Full Text] [Related]  

  • 23. Patient-Centered Approach for Hypertension Management in End-Stage Kidney Disease: Art or Science?
    Gosmanova EO; Kovesdy CP
    Semin Nephrol; 2018 Jul; 38(4):355-368. PubMed ID: 30082056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of one year of hemodialysis on weight and blood pressure in 434 patients.
    Salem MM; Davis M
    Artif Organs; 1997 May; 21(5):402-4. PubMed ID: 9129772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aortic Stiffness, Ambulatory Blood Pressure, and Predictors of Response to Antihypertensive Therapy in Hemodialysis.
    Georgianos PI; Agarwal R
    Am J Kidney Dis; 2015 Aug; 66(2):305-12. PubMed ID: 25818679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistant and Refractory Hypertension: Antihypertensive Treatment Resistance vs Treatment Failure.
    Siddiqui M; Dudenbostel T; Calhoun DA
    Can J Cardiol; 2016 May; 32(5):603-6. PubMed ID: 26514749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics of resistant hypertension evaluated by ambulatory blood pressure monitoring.
    Kansui Y; Matsumura K; Kida H; Sakata S; Ohtsubo T; Ibaraki A; Kitazono T
    Clin Exp Hypertens; 2014; 36(7):454-8. PubMed ID: 24164430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia.
    Zhang J; Healy HG; Venuthurupalli SK; Tan KS; Wang Z; Cameron A; Hoy WE
    BMC Nephrol; 2019 Sep; 20(1):348. PubMed ID: 31484506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of hypertension in hemodialysis patients.
    Ram CV; Fenves AZ
    Curr Hypertens Rep; 2009 Aug; 11(4):292-8. PubMed ID: 19602331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ; Ceballos M;
    Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension in hemodialysis patients.
    Querques M; Manunta P
    Minerva Urol Nefrol; 2010 Mar; 62(1):41-50. PubMed ID: 20424569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Office blood pressure threshold of 130/80 mmHg better predicts uncontrolled out-of-office blood pressure in apparent treatment-resistant hypertension.
    Lee CJ; Ha JH; Kim JY; Kim IC; Ryu SK; Rhee MY; Lee JH; Lee JH; Lee HY; Ihm SH; Chung JW; Choi JH; Shin J; Park S; Kario K
    J Clin Hypertens (Greenwich); 2021 Mar; 23(3):595-605. PubMed ID: 33280228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Clinical Problems of Hypertension Treatment in Hemodialysis Patients.
    Loutradis CN; Tsioufis C; Sarafidis PA
    Curr Vasc Pharmacol; 2017; 16(1):54-60. PubMed ID: 28413966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
    Azizi M; Pereira H; Hamdidouche I; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Girerd X; Michel Halimi J; Zannad F; Ormezzano O; Vaïsse B; Herpin D; Ribstein J; Chamontin B; Mourad JJ; Ferrari E; Plouin PF; Jullien V; Sapoval M; Chatellier G;
    Circulation; 2016 Sep; 134(12):847-57. PubMed ID: 27576780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is resistant arterial hypertension?
    Shalaeva EV; Messerli FH
    Blood Press; 2023 Dec; 32(1):2185457. PubMed ID: 36891929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Optimal Blood Pressure Target in Different Dialysis Populations.
    Jhee JH; Park J; Kim H; Kee YK; Park JT; Han SH; Yang CW; Kim NH; Kim YS; Kang SW; Kim YL; Yoo TH
    Sci Rep; 2018 Sep; 8(1):14123. PubMed ID: 30237432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of hypertension in renal failure patients: when do we overtreat? When do we undertreat?
    Rosansky SJ
    Blood Purif; 1996; 14(4):315-20. PubMed ID: 8873957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension in patients on dialysis: diagnosis, mechanisms, and management.
    Bucharles SGE; Wallbach KKS; Moraes TP; Pecoits-Filho R
    J Bras Nefrol; 2019; 41(3):400-411. PubMed ID: 30421784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.
    Howard VJ; Tanner RM; Anderson A; Irvin MR; Calhoun DA; Lackland DT; Oparil S; Muntner P
    Am J Med; 2015 Jul; 128(7):707-14.e2. PubMed ID: 25770032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-World Treatment of Hypertension on Hemodialyses Data from a Large Polish Database.
    Symonides B; Zaborska-Dworak M; Lewandowski J; Marcinkowski W; Zawierucha J; Prystacki T; Małyszko J
    Kidney Blood Press Res; 2024; 49(1):630-636. PubMed ID: 39008952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.